BAX and breast carcinoma: Indeed, all tumors with stabilized mutp53, including the single ‘outlier' breast cancer tested, had reduced or undetectable Mdm2 and p21 levels, respectively, and sarcomas also had reduced Bax and Puma expression correlating with their LOH.